Dr. Michel Janicot has served as head of preclinical research & development since July 2012. He has over 20 years of pharmaceutical industry experience in oncology R&D. Prior to joining the company, he was Senior Director at Janssen R&D (Johnson&Johnson) located in Beerse, Belgium and then founded his own consulting firm (JMi ONConsulting). He has managed large multidisciplinary teams for the worldwide preclinical and early clinical development of both small molecules and biologics drug candidates for oncology intervention. His management expertise, leadership, and strategic vision, combined with extensive experience with large pharma companies such as Johnson&Johnson and Sanofi (formerly Rhône-Poulenc Rorer), covers a large scope of the drug development process – from discovery to early clinical development. He has a doctorate in biochemistry from the University Paris VII, France, obtained in 1988 and did a postdoctoral training at The Johns Hopkins University, Baltimore, MD (USA) from 1988 to 1992.